The report provides a detailed analysis essential for establishing a thrombin production plant. It encompasses all critical aspects necessary for thrombin production, including the cost of thrombin production, thrombin plant cost, thrombin production costs, and the overall thrombin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a thrombin production plant.
These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Thrombin is a proteolytic enzyme that plays a physiological role in maintaining blood coagulation and regulating homeostasis. It is extensively used as a topical homeostatic agent to minimize and control blood loss during surgical procedures. It is often used as a tissue adhesive to promote wound healing and surgical incision recovery. Additionally, it is also utilized in the research, development, and testing of new anticoagulant drugs.
The market for thrombin is majorly driven by its application as an alternative to standard surgical techniques and as a component in fibrin sealant to promote the healing process of the wound, which boosts its market growth. Its application as a hemostatic agent to promote clot formation and control bleeding during surgeries significantly propels its demand in the medical and pharmaceutical industries. Its usage for drug development and research purposes further enhances its demand in the pharmaceutical research and biotechnology industries.
Additionally, several factors influence industrial thrombin procurement, such as the source and purity, cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Thrombin Production
According to the Thrombin production plant project report, the major raw material for Thrombin production includes Human Blood Plasma.
Production Process of Thrombin
The extensive Thrombin production cost report consists of the following industrial production process:
- Production from Human Blood Plasma: Thrombin is produced from human blood plasma in a multi-step process starting with a 1200 L batch. Initially, prothrombin is extracted using a sequence of techniques: cryoprecipitation, dual ion-exchange chromatography (DEAE-IEX), heparin affinity chromatography, and immobilized metal-affinity chromatography (IMAC). The isolated prothrombin is then converted into thrombin and further purified through hydrophobic interaction chromatography (HIC), followed by concentration via ultrafiltration.
Thrombin is a globular protein and is also known as a coagulation factor. It is soluble in water. The molecular formula for thrombin is C54H84N16O18, and its molecular weight is 36000 Da. The density of the enzyme falls between 1.3 to 1.4 g/cm3. It is an α/β heterodimer that comprises 36 amino acid A chains and 259 amino acid B chains that are connected by a disulfide bridge between Cys1 and Cys122, apart from 3 other intrachain disulfide bonds. It acts by facilitating the clotting of blood by catalyzing the conversion of fibrinogen to fibrin. It is available as a powder in dosage form.